<html>
	<head>
		<title>epitope <epto> sets three for one stock split</title>
</head>
<body>
	<h3>epitope inc said its board of directors has authorized a three-for-one common stock split for which shareholder approval is expected in the next two weeks.     the company announced a two-for-one split last week, but said the board reconvened and agreed to change it to a three-for-one split.     epitope is involved in the production of monoclonal antibodies for diagnostic and therapeutic use in aids and other immunological diseases.  reuter &#3;</h3>
</body>
</html>